Dr. Wishna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7400 State Line Road
Prairie Village, KS 66208Phone+1 913-588-6600
Summary
- Anne (Berenbom) Wishna, MD, is an ophthalmologist based in Prairie Village, KS, with subspecialties in cataract-related and dry eye disease. She completed her medical education at Washington University in St. Louis, followed by an internship at Louis A Weiss Memorial Hospital and a residency in ophthalmology at Icahn School of Medicine at Mount Sinai. Dr. Wishna is a Clinical Associate Professor of Ophthalmology and Director of the ophthalmology residncy program at The University of Kansas Health System, where she has worked since 2017. Her experience includes glaucoma and related disorders, cataract surgery, cornea/external disease, comprehensive ophthalmology, and neurophthalmology. She has published research on Belantamab in combination with Dexamethasone, cited 10 times, in Clinical Lymphoma, Myeloma & Leukemia.
Education & Training
- Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary at Mount SinaiResidency, Ophthalmology, 2006 - 2009
- Louis A Weiss Memorial HospitalInternship, Transitional Year, 2005 - 2006
- Washington University in St. Louis School of MedicineClass of 2005
Certifications & Licensure
- AZ State Medical License 2018 - 2027
- MO State Medical License 2010 - 2026
- KS State Medical License 2010 - 2025
- NY State Medical License 2006 - 2012
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Comparative insights into the role of sex hormones in glaucoma among women and men.Sharon H Zhao, Christine K Kim, Tala Al-Khaled, Margaret Ann Chervinko, Anne Wishna
Progress in Retinal and Eye Research. 2025-03-01 - 9 citationsBelantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma.Tahani Atieh, Shebli Atrash, Nausheen Ahmed, Meera Mohan, Wei Cui
Clinical Lymphoma, Myeloma & Leukemia. 2022-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: